Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin alfa for mild neonatal encephalopathy
NCT03071861Phase 2Completed
- Sponsor
- The University of New Mexico
- Start
- Dec 2017
- Primary completion
- Dec 2019
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of darbepoetin alfa in hypoxic-ischemic encephalopathy (HIE), sponsored by The University of New Mexico. Started Dec 2017; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT03071861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03071861.